TY - JOUR
T1 - Navigating the landscape of core outcome set development in dermatology
AU - Prinsen, Cecilia A. C.
AU - Spuls, Phyllis I.
AU - Kottner, Jan
AU - Thomas, Kim S.
AU - Apfelbacher, Christian
AU - Chalmers, Joanne R.
AU - Deckert, Stefanie
AU - Furue, Masutaka
AU - Gerbens, Louise
AU - Kirkham, Jamie
AU - Simpson, Eric L.
AU - Alam, Murad
AU - Balzer, Katrin
AU - Beeckman, Dimitri
AU - Eleftheriadou, Viktoria
AU - Ezzedine, Khaled
AU - Horbach, Sophie E. R.
AU - Ingram, John R.
AU - Layton, Alison M.
AU - Weller, Karsten
AU - Wild, Thomas
AU - Wolkerstorfer, Albert
AU - Williams, Hywel C.
AU - Schmitt, Jochen
N1 - Copyright © 2019 American Academy of Dermatology, Inc. All rights reserved.
PY - 2019/7
Y1 - 2019/7
N2 - The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific condition) in dermatology is increasing in pace. A total of 44 dermatology-related COS projects have been registered in the online Core Outcome Measures in Effectiveness Trials database (http://www.comet-initiative.org/studies/search) and include studies on 26 different skin diseases. With the increasing number of COSs in dermatology, care is needed to ensure the delivery of high-quality COSs that meet quality standards when using state-of-the-art methods. In 2015, the Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) was established. CS-COUSIN is an international, multidisciplinary working group aiming to improve the development and implementation of COSs in dermatology. CS-COUSIN has developed guidance on how to develop high-quality COSs for skin diseases and supports dermatology-specific COS initiatives. Currently, 17 COS development groups are affiliated with CS-COUSIN and following standardized COS development processes. To ensure successful uptake of COSs in dermatology, researchers, clinicians, systematic reviewers, guideline developers, and other stakeholders should use existing COSs in their work.
AB - The development of core outcome sets (COSs; ie, a minimum set of core outcomes that should be measured and reported in all trials or in clinical practice for a specific condition) in dermatology is increasing in pace. A total of 44 dermatology-related COS projects have been registered in the online Core Outcome Measures in Effectiveness Trials database (http://www.comet-initiative.org/studies/search) and include studies on 26 different skin diseases. With the increasing number of COSs in dermatology, care is needed to ensure the delivery of high-quality COSs that meet quality standards when using state-of-the-art methods. In 2015, the Cochrane Skin–Core Outcome Set Initiative (CS-COUSIN) was established. CS-COUSIN is an international, multidisciplinary working group aiming to improve the development and implementation of COSs in dermatology. CS-COUSIN has developed guidance on how to develop high-quality COSs for skin diseases and supports dermatology-specific COS initiatives. Currently, 17 COS development groups are affiliated with CS-COUSIN and following standardized COS development processes. To ensure successful uptake of COSs in dermatology, researchers, clinicians, systematic reviewers, guideline developers, and other stakeholders should use existing COSs in their work.
KW - CS-COUSIN
KW - Cochrane Skin
KW - clinical trials
KW - core outcome set
KW - dermatology
KW - development
KW - implementation
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85067479598&origin=inward
UR - https://www.ncbi.nlm.nih.gov/pubmed/30878565
U2 - https://doi.org/10.1016/j.jaad.2019.03.009
DO - https://doi.org/10.1016/j.jaad.2019.03.009
M3 - Article
C2 - 30878565
SN - 0190-9622
VL - 81
SP - 297
EP - 305
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 1
ER -